{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T16:59:55Z","timestamp":1795193995192,"version":"4.10.3"},"reference-count":159,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Fibrosis is an unavoidable consequence of chronic inflammation. Extracellular matrix deposition by fibroblasts, stimulated by multiple pathways, is the first step in the onset of chronic liver disease, and its propagation promotes liver dysfunction. At the same time, chronic liver disease is characterized by alterations in primary and secondary hemostasis but unlike previously thought, these changes are not associated with an increased risk of bleeding complications. In recent years, the role of coagulation imbalance has been postulated as one of the main mechanisms promoting hepatic fibrogenesis. In this review, we aim to investigate the function of microvascular thrombosis in the progression of liver disease and highlight the molecular and cellular networks linking hemostasis to fibrosis in this context. We analyze the predictive and prognostic role of coagulation products as biomarkers of liver decompensation (ascites, variceal hemorrhage, and hepatic encephalopathy) and liver-related mortality. Finally, we evaluate the current evidence on the application of antiplatelet and anticoagulant therapies for prophylaxis of hepatic decompensation or prevention of the progression of liver fibrosis.<\/jats:p>","DOI":"10.3390\/cells12131712","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T02:23:09Z","timestamp":1687746189000},"page":"1712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-924X","authenticated-orcid":false,"given":"Carlo","family":"Airola","sequence":"first","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pallozzi","sequence":"additional","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cerrito","sequence":"additional","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-1171","authenticated-orcid":false,"given":"Francesco","family":"Santopaolo","sequence":"additional","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-0803","authenticated-orcid":false,"given":"Leonardo","family":"Stella","sequence":"additional","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-1779","authenticated-orcid":false,"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-6238","authenticated-orcid":false,"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[{"name":"Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014A Common Pathway to Organ Injury and Failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium Structure and Function in Kidney Health and Disease","volume":"15","author":"Fakhouri","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1513\/pats.201201-006AW","article-title":"Coagulation Cascade Proteinases in Lung Injury and Fibrosis","volume":"9","author":"Chambers","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.1840050422","article-title":"Acute and Chronic Changes in the Microcirculation of the Liver in Inbred Strains of Mice Following Infection with Mouse Hepatitis Virus Type 3","volume":"5","author":"Macphee","year":"1985","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0026-2862(88)90014-3","article-title":"Microcirculatory Changes in Livers of Mice Infected with Murine Hepatitis Virus. Evidence from Microcorrosion Casts and Measurements of Red Cell Velocity","volume":"36","author":"MacPhee","year":"1988","journal-title":"Microvasc. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.1840030614","article-title":"The Effect of Mouse Hepatitis Virus Infection on the Microcirculation of the Liver","volume":"3","author":"Levy","year":"2007","journal-title":"Hepatology"},{"key":"ref_7","first-page":"1232","article-title":"Role of Thrombosis in the Pathogenesis of Congestive Hepatic Fibrosis (Cardiac Cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11901-020-00508-y","article-title":"The Role of Vascular Injury and Congestion in the Pathogenesis of Cirrhosis: The Congestive Escalator and the Parenchymal Extinction Sequence","volume":"19","author":"Wanless","year":"2020","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0030-1255350","article-title":"Inflammation and Hepatic Fibrosis","volume":"30","author":"Bissell","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic Passive Venous Congestion Drives Hepatic Fibrogenesis via Sinusoidal Thrombosis and Mechanical Forces","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/09537104.2020.1817360","article-title":"Immunothrombosis and Thromboinflammation in Host Defense and Disease","volume":"32","author":"Martinod","year":"2021","journal-title":"Platelets"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.it.2021.04.001","article-title":"Emerging Mechanisms of Immunocoagulation in Sepsis and Septic Shock","volume":"42","author":"Tang","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1039843","DOI":"10.3389\/fimmu.2022.1039843","article-title":"Platelet in Thrombo-Inflammation: Unraveling New Therapeutic Targets","volume":"13","author":"Sharma","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"866746","DOI":"10.3389\/fmed.2022.866746","article-title":"The Therapeutic Potential of Anticoagulation in Organ Fibrosis","volume":"9","author":"Oh","year":"2022","journal-title":"Front. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"636843","DOI":"10.3389\/fcvm.2021.636843","article-title":"Microvascular Angiopathic Consequences of COVID-19","volume":"8","author":"Nalugo","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.dld.2021.12.014","article-title":"Hepatocellular Liver Injury in Hospitalized Patients Affected by COVID-19: Presence of Different Risk Factors at Different Time Points","volume":"54","author":"Leo","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/apt.15996","article-title":"\u201cGemelli against COVID-19\u201d group. Liver Involvement Is Not Associated with Mortality: Results from a Large Cohort of SARS-CoV-2 Positive Patients","volume":"52","author":"Ponziani","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/liv.14601","article-title":"Liver Histopathology in Severe COVID 19 Respiratory Failure Is Suggestive of Vascular Alterations","volume":"40","author":"Sonzogni","year":"2020","journal-title":"Liver Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/hepr.13696","article-title":"Pathological Characteristics of Liver Sinusoidal Thrombosis in COVID-19 Patients: A Series of 43 Cases","volume":"51","author":"Kondo","year":"2021","journal-title":"Hepatol. Res."},{"key":"ref_20","first-page":"13072","article-title":"Prevalence of Liver Injury and Correlation with Clinical Outcomes in Patients with COVID-19: Systematic Review with Meta-Analysis","volume":"24","author":"Ianiro","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Moya, L., Farashi, S., Suravajhala, P., Janaththani, P., and Batra, J. (2022). Severe COVID-19 May Impact Hepatic Fibrosis \/Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study. Genes, 14.","DOI":"10.3390\/genes14010022"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of Severe Illness from COVID-19 in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Increased Fibrosis Scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin Reduces Hepatic Vascular Resistance and Portal Pressure in Cirrhotic Rats","volume":"64","author":"Cerini","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hep.29084","article-title":"The Anticoagulant Rivaroxaban Lowers Portal Hypertension in Cirrhotic Rats Mainly by Deactivating Hepatic Stellate Cells","volume":"65","author":"Vilaseca","year":"2017","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"814496","DOI":"10.3389\/fmed.2021.814496","article-title":"Liver Fibrosis\u2014From Mechanisms of Injury to Modulation of Disease","volume":"8","author":"Liedtke","year":"2022","journal-title":"Front. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of Hepatic Fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia-Induced VEGF and Collagen I Expressions Are Associated with Angiogenesis and Fibrogenesis in Experimental Cirrhosis: Hypoxia-Induced VEGF and Collagen I Expressions Are Associated with Angiogenesis and Fibrogenesis in Experimental Cirrhosis","volume":"35","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1050-1738(02)00153-6","article-title":"Orchestration of Coagulation Protease Signaling by Tissue Factor","volume":"12","author":"Riewald","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.00044.2021","article-title":"Protease-Activated Receptors in Health and Disease","volume":"103","author":"Peach","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2003-04-1130","article-title":"Protease-Activated Receptors 1 and 4 Mediate Thrombin Signaling in Endothelial Cells","volume":"102","author":"Kataoka","year":"2003","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1160\/TH07-08-0481","article-title":"Thrombin and Protease-Activated Receptors (PARs) in Atherothrombosis","volume":"99","author":"Martorell","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/jcmm.12520","article-title":"Protease-Activated Receptor (PAR)-2 Is Required for PAR-1 Signalling in Pulmonary Fibrosis","volume":"19","author":"Lin","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1164\/rccm.201009-1479OC","article-title":"Role of Protease-Activated Receptor-2 in Idiopathic Pulmonary Fibrosis","volume":"183","author":"Wygrecka","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e015616","DOI":"10.1161\/JAHA.119.015616","article-title":"Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice","volume":"9","author":"Yokono","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the Fibrotic Niche of Human Liver Cirrhosis at Single-Cell Level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of Hepatic Stellate Cell Proliferation and Collagen Synthesis by Proteinase-Activated Receptors","volume":"36","author":"Zhou","year":"2002","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/bj3330121","article-title":"Thrombin Stimulates Fibroblast Procollagen Production via Proteolytic Activation of Protease-Activated Receptor 1","volume":"333","author":"Chambers","year":"1998","journal-title":"Biochem. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"G226","DOI":"10.1152\/ajpgi.00444.2007","article-title":"Protease-Activated Receptor 1 Knockout Reduces Experimentally Induced Liver Fibrosis","volume":"294","author":"Rullier","year":"2008","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Dhar, A., Sadiq, F., Anstee, Q.M., Levene, A.P., Goldin, R.D., and Thursz, M.R. (2018). Thrombin and Factor Xa Link the Coagulation System with Liver Fibrosis. BMC Gastroenterol., 18.","DOI":"10.1186\/s12876-018-0789-8"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 Antagonism Protects against Experimental Liver Fibrosis. Role of Proteinase Receptors in Stellate Cell Activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/rth2.12403","article-title":"Liver Fibrosis Is Driven by Protease-activated Receptor-1 Expressed by Hepatic Stellate Cells in Experimental Chronic Liver Injury","volume":"4","author":"Poole","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ajpath.2012.06.011","article-title":"Therapeutic Administration of the Direct Thrombin Inhibitor Argatroban Reduces Hepatic Inflammation in Mice with Established Fatty Liver Disease","volume":"181","author":"Kassel","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.ajpath.2011.07.015","article-title":"Protease-Activated Receptor 1 and Hematopoietic Cell Tissue Factor Are Required for Hepatic Steatosis in Mice Fed a Western Diet","volume":"179","author":"Kassel","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/toxsci\/kfw175","article-title":"From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis","volume":"154","author":"Nault","year":"2016","journal-title":"Toxicol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1440-1746.2007.05220.x","article-title":"Effect of a Thrombin Receptor (Protease-Activated Receptor 1, PAR-1) Gene Polymorphism in Chronic Hepatitis C Liver Fibrosis","volume":"23","author":"Martinelli","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00428-005-0078-0","article-title":"Expression of Protease-Activated Receptors and Tissue Factor in Human Liver","volume":"448","author":"Rullier","year":"2006","journal-title":"Virchows Arch."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The Coagulation System Contributes to AV\u03b26 Integrin Expression and Liver Fibrosis Induced by Cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.102.046391","article-title":"Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers","volume":"305","author":"Copple","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"936196","DOI":"10.3389\/fimmu.2022.936196","article-title":"The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis","volume":"13","author":"Du","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver Sinusoidal Endothelial Cells: Physiology and Role in Liver Diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2013.06.017","article-title":"Hepatic Ischemia and Reperfusion Injury: Effects on the Liver Sinusoidal Milieu","volume":"59","author":"Peralta","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.pharep.2015.04.010","article-title":"Liver Sinusoidal Endothelial Cells (LSECs) Function and NAFLD; NO-Based Therapy Targeted to the Liver","volume":"67","author":"Maslak","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/82161","article-title":"Efficient Presentation of Exogenous Antigen by Liver Endothelial Cells to CD8+ T Cells Results in Antigen-Specific T-Cell Tolerance","volume":"6","author":"Limmer","year":"2000","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.4049\/jimmunol.1002961","article-title":"Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium","volume":"186","author":"Shetty","year":"2011","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.3748\/wjg.v11.i44.6936","article-title":"Fibrinogen-like Protein 2 Fibroleukin Expression and Its Correlation with Disease Progression in Murine Hepatitis Virus Type 3-Induced Fulminant Hepatitis and in Patients with Severe Viral Hepatitis B","volume":"11","author":"Zhu","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/hum.2006.17.589","article-title":"Novel Mfgl2 Antisense Plasmid Inhibits Murine Fgl2 Expression and Ameliorates Murine Hepatitis Virus Type 3-Induced Fulminant Hepatitis in BALB\/CJ Mice","volume":"17","author":"Zhu","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI18114","article-title":"The Fgl2\/Fibroleukin Prothrombinase Contributes to Immunologically Mediated Thrombosis in Experimental and Human Viral Hepatitis","volume":"112","author":"Marsden","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.gastro.2019.03.013","article-title":"Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension","volume":"157","author":"Hilscher","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil Extracellular Traps Promote Inflammation and Development of Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis","volume":"68","author":"Sud","year":"2018","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular Occlusion by Neutrophil Extracellular Traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil Extracellular Traps Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jss.2019.09.044","article-title":"Antiapoptotic Effect by PAR-1 Antagonist Protects Mouse Liver Against Ischemia-Reperfusion Injury","volume":"246","author":"Noguchi","year":"2020","journal-title":"J. Surg. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.20031132","article-title":"KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation","volume":"199","author":"SenBanerjee","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1089\/ars.2010.3647","article-title":"\u201cGo With the Flow\u201d: How Kr\u00fcppel-Like Factor 2 Regulates the Vasoprotective Effects of Shear Stress","volume":"15","author":"Nayak","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.ATV.0000215638.53414.99","article-title":"Kruppel-Like Factor 2 Inhibits Protease Activated Receptor-1 Expression and Thrombin-Mediated Endothelial Activation","volume":"26","author":"Lin","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The Transcription Factor KLF2 Mediates Hepatic Endothelial Protection and Paracrine Endothelial\u2013Stellate Cell Deactivation Induced by Statins","volume":"58","author":"Marrone","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 Exerts Antifibrotic and Vasoprotective Effects in Cirrhotic Rat Livers: Behind the Molecular Mechanisms of Statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal Communication in Liver Fibrosis and Regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1161\/01.RES.0000267856.00713.0a","article-title":"Role of Kr\u00fcppel-Like Transcription Factors in Endothelial Biology","volume":"100","author":"Atkins","year":"2007","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"109809","DOI":"10.1016\/j.cbi.2022.109809","article-title":"PAR1, a Therapeutic Target for Remote Lung Injury Associated with Hind Limb Ischemia\/Reperfusion: ERK5\/KLF2-Dependent Lung Capillary Barrier Preservation","volume":"354","author":"Kamel","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Chen, T., Shi, Z., Zhao, Y., Meng, X., Zhao, S., Zheng, L., Han, X., Hu, Z., Yao, Q., and Lin, H. (2022). LncRNA Airn Maintains LSEC Differentiation to Alleviate Liver Fibrosis via the KLF2-ENOS-SGC Pathway. BMC Med., 20.","DOI":"10.1186\/s12916-022-02523-w"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between Platelets and Coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1465-9921-4-13","article-title":"Platelets Stimulate Fibroblast-Mediated Contraction of Collagen Gels","volume":"4","author":"Zagai","year":"2003","journal-title":"Respir. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"643815","DOI":"10.3389\/fonc.2021.643815","article-title":"The Provocative Roles of Platelets in Liver Disease and Cancer","volume":"11","author":"Fowlkes","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1037645","DOI":"10.3389\/fimmu.2022.1037645","article-title":"The Role of Platelet Mediated Thromboinflammation in Acute Liver Injury","volume":"13","author":"Morris","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11239-021-02381-y","article-title":"Edoxaban, a Direct Oral Factor Xa Inhibitor, Ameliorates Coagulation, Microvascular Thrombus Formation, and Acute Liver Injury in a Lipopolysaccharide-Induced Coagulopathy Model in Rats","volume":"52","author":"Morishima","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"G304","DOI":"10.1152\/ajpgi.2000.279.2.G304","article-title":"Biological Activities of Novel Lipid Mediator Sphingosine 1-Phosphate in Rat Hepatic Stellate Cells","volume":"279","author":"Ikeda","year":"2000","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"15308","DOI":"10.1038\/s41598-021-94052-4","article-title":"Sphingosine-1-Phosphate Modulates PAR1-Mediated Human Platelet Activation in a Concentration-Dependent Biphasic Manner","volume":"11","author":"Liu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"CXC Chemokine Ligand 4 (Cxcl4) Is a Platelet-Derived Mediator of Experimental Liver Fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"Hepatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","article-title":"Extrahepatic Platelet-Derived Growth Factor-\u03b2, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice","volume":"147","author":"Yoshida","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI114363","article-title":"Effects of Platelet-Derived Growth Factor and Other Polypeptide Mitogens on DNA Synthesis and Growth of Cultured Rat Liver Fat-Storing Cells","volume":"84","author":"Pinzani","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Karolczak, K., and Watala, C. (2021). Blood Platelets as an Important but Underrated Circulating Source of TGF\u03b2. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094492"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 Is a Mediator and Potential Interventional Target for NASH and Subsequent Liver Cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0268-960X(93)90024-X","article-title":"Platelet \u03b1-Granules","volume":"7","author":"Harrison","year":"1993","journal-title":"Blood Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","article-title":"Antiplatelet Therapy Prevents Hepatocellular Carcinoma and Improves Survival in a Mouse Model of Chronic Hepatitis B","volume":"109","author":"Sitia","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12664-021-01230-3","article-title":"Antiplatelet Therapy Associated with Lower Prevalence of Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"41","author":"Thongtan","year":"2022","journal-title":"Indian J. Gastroenterol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/09537104.2021.1883574","article-title":"Antiplatelet Drugs and Liver Fibrosis","volume":"33","author":"Czajka","year":"2022","journal-title":"Platelets"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/SLA.0b013e31818584c7","article-title":"Single Administration of Thrombopoietin Prevents Progression of Liver Fibrosis and Promotes Liver Regeneration After Partial Hepatectomy in Cirrhotic Rats","volume":"248","author":"Murata","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1872-034X.2011.00893.x","article-title":"Platelet-Derived Adenosine 5\u2032-Triphosphate Suppresses Activation of Human Hepatic Stellate Cell: In Vitro Study: Platelets Control Hepatic Stellate Cells","volume":"42","author":"Ikeda","year":"2012","journal-title":"Hepatol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1053\/j.gastro.2010.02.054","article-title":"Thrombocytopenia Exacerbates Cholestasis-Induced Liver Fibrosis in Mice","volume":"138","author":"Kodama","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/09537104.2021.2002836","article-title":"Relationship between Hepatitis B Virus Infection and Platelet Production and Dysfunction","volume":"33","author":"Jiang","year":"2022","journal-title":"Platelets"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.12770","article-title":"Coagulation-driven Platelet Activation Reduces Cholestatic Liver Injury and Fibrosis in Mice","volume":"13","author":"Joshi","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A Dual Thrombin Receptor System for Platelet Activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ajg.2016.498","article-title":"Changing concepts of cirrhotic coagulopathy","volume":"112","author":"Tripodi","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors inplasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.23653","article-title":"Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method","volume":"52","author":"Tripodi","year":"2010","journal-title":"Hepatology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11739-011-0528-4","article-title":"Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: Considerations on the efficacy of treatment with fresh-frozen plasma","volume":"7","author":"Tripodi","year":"2012","journal-title":"Intern. Emerg. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/jth.14011","article-title":"Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis","volume":"16","author":"Sinegre","year":"2018","journal-title":"J. Thromb Haemost."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e025656","DOI":"10.1136\/bmjopen-2018-025656","article-title":"von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: A systematic review and meta-analysis","volume":"9","author":"Zou","year":"2019","journal-title":"BMJ Open"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jth.12412","article-title":"Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII","volume":"12","author":"Shahani","year":"2014","journal-title":"J. Thromb Haemost."},{"key":"ref_102","first-page":"58","article-title":"Endothelium releases more von Willebrand factor and tissue-type plasminogen activator upon venous occlusion in patients with liver cirrhosis than in normals","volume":"23","author":"Tornai","year":"1993","journal-title":"Haemostasis"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"Reverter","year":"2011","journal-title":"Gut"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/apt.12564","article-title":"Ferlitsch Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"39","author":"Maieron","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"Willebrand factor biosynthesis, secretion, and clearance: Connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/blood-2015-12-684688","article-title":"Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo","volume":"128","author":"Pan","year":"2016","journal-title":"Blood"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease?","volume":"130","author":"Soejima","year":"2001","journal-title":"J. Biochem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2003.11.111","article-title":"Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets","volume":"313","author":"Suzuki","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/labinvest.3700275","article-title":"ADAMTS13 is expressed in hepatic stellate cells","volume":"85","author":"Zhou","year":"2005","journal-title":"Lab. Investig."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","article-title":"Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis","volume":"99","author":"Uemura","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","article-title":"Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity","volume":"99","author":"Kokame","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2007.06688.x","article-title":"ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis","volume":"138","author":"Feys","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"264S","DOI":"10.1097\/01.alc.0000192326.08931.cb","article-title":"Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis","volume":"29","author":"Uemura","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1530-0277.2006.00283.x","article-title":"Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis","volume":"31","author":"Matsuyama","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_120","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02981975","article-title":"Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int. J. Hematol."},{"key":"ref_123","first-page":"71","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome","volume":"30","author":"Furlan","year":"2000","journal-title":"Adv. Nephrol. Necker. Hosp."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2016.06.002","article-title":"von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia","volume":"65","author":"Kalambokis","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2021.12.038","article-title":"Factor VIII\/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD","volume":"76","author":"Scheiner","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1016\/j.jhep.2022.12.027","article-title":"From coagulation imbalance to prediction of advanced chronic liver disease decompensation: The wind of change?","volume":"76","author":"Ponziani","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Takaya, H., Namisaki, T., Asada, S., Iwai, S., Kubo, T., Suzuki, J., Enomoto, M., Tsuji, Y., Fujinaga, Y., and Nishimura, N. (2022). ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071835"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.14522","article-title":"Vienna Hepatic Hemodynamic Lab. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity","volume":"47","author":"Mandorfer","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/liv.12657","article-title":"Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis","volume":"35","author":"Reuken","year":"2015","journal-title":"Liver Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/br.2017.945","article-title":"Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure","volume":"7","author":"Takaya","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Takaya, H., Namisaki, T., Enomoto, M., Kubo, T., Tsuji, Y., Fujinaga, Y., Nishimura, N., Kaji, K., Kawaratani, H., and Moriya, K. (2023). The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology, 12.","DOI":"10.3390\/biology12020164"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/hep.31507","article-title":"VWF\/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure","volume":"73","author":"Driever","year":"2021","journal-title":"Hepatology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMra2021808","article-title":"The Evolving Challenge of Infections in Cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_134","first-page":"950","article-title":"Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells","volume":"67","author":"Carnevale","year":"2017","journal-title":"Implic. Hypercoagulability Cirrhosis. J Hepatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"goac065","DOI":"10.1093\/gastro\/goac065","article-title":"Low ADAMTS-13\/VWF ratio and altered gut-liver axis predict complications of advanced chronic liver disease: A pilot study","volume":"10","author":"Ponziani","year":"2022","journal-title":"Gastroenterol. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1530-0277.2008.00850.x","article-title":"Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: Relationship to endotoxemia","volume":"34","author":"Ishikawa","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10620-006-9595-1","article-title":"The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis","volume":"52","author":"Assy","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","author":"Abe","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","article-title":"A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat","volume":"51","author":"Baiuomy","year":"2005","journal-title":"Pharmacol. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"8887574","DOI":"10.1155\/2020\/8887574","article-title":"Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis","volume":"2020","author":"Zhang","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.13510","article-title":"Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis","volume":"38","author":"Fortea","year":"2018","journal-title":"Liver Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10620-018-5311-1","article-title":"Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats","volume":"64","author":"Lee","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e22287","DOI":"10.1002\/jbt.22287","article-title":"Inhibition of activated factor X; a new pathway in ameliorating carbon tetrachloride-induced liver fibrosis in rats","volume":"33","author":"Mahmoud","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"116522","DOI":"10.1016\/j.lfs.2019.05.078","article-title":"Interruption of platelets and thrombin function as a new approach against liver fibrosis induced experimentally in rats","volume":"231","author":"Mahmoud","year":"2019","journal-title":"Life Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.3748\/wjg.v23.i35.6412","article-title":"Effects of aspirin and enoxaparin in a rat model of liver fibrosis","volume":"23","author":"Li","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/gut.2007.144550","article-title":"Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease","volume":"57","author":"Fujita","year":"2008","journal-title":"Gut"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clinre.2014.07.004","article-title":"Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation","volume":"38","author":"Conti","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa1912035","article-title":"Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality","volume":"382","author":"Simon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2015.10.007","article-title":"Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis","volume":"150","author":"Mohanty","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2014.08.013","article-title":"Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C","volume":"62","author":"Simon","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2015.02.027","article-title":"Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis","volume":"63","author":"Bitto","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: A randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2018.07.022","article-title":"Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension","volume":"155","author":"Tripathi","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"La Mura, V., Gagliano, N., Arnaboldi, F., Sartori, P., Procacci, P., Denti, L., Liguori, E., Bitto, N., Ristagno, G., and Latini, R. (2022). Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia. Cells, 11.","DOI":"10.3390\/cells11071148"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/13\/1712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:59:37Z","timestamp":1760126377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/13\/1712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":159,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["cells12131712"],"URL":"https:\/\/doi.org\/10.3390\/cells12131712","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]}}}